Therapeutic Asset Ratings
748 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Autologous Neoantigen-Pulsed Dendritic Cell Vaccine
Prostate Neoplasm
Changhai Hospital
P1
CC
(43)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine
Breast Carcinoma
University of Washington
P1
CC
(43)
Cp-Il22Bp Mrna Intratumorally
Metastatic Malignant Neoplasm
West China Hospital
P1
CC
(43)
Cp-Il22Bp Mrna Intratumorally
mRNA Vaccine
West China Hospital
P1
CC
(43)
Cp-Il22Bp Mrna Intratumorally
Peptides
West China Hospital
P1
CC
(43)
Dnajb1-Prkaca Peptide Vaccine
Fibrolamellar Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
P1
CC
(43)
Ebv Mrna Vaccine
Epstein-Barr Virus-Related Tumor
Sun Yat-sen University
P1
CC
(43)
Engineered Mitochondrial Vaccine
Neoplasm
West China Hospital
P1
CC
(43)
Falimarev
Pancreatic Acinar Cell Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Falimarev
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Fluzone Quadrivalent
Triple-Negative Breast Carcinoma
Rush University Medical Center
P1
CC
(43)
Fusion-Vac-Xs15
Fibrolamellar Hepatocellular Carcinoma
University Hospital Tuebingen
P1
CC
(43)
Grt-C903
Malignant Urinary System Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Grt-C903
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Grt-R904
Malignant Urinary System Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Grt-R904
Metastatic Malignant Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
h3k27m peptide vaccine
Diffuse Midline Glioma, H3 K27-Altered
German Cancer Research Center
P1
CC
(43)
Hcv Dna Vaccine Ino-8000
Hepatitis
National Cancer Institute (NCI)
P1
CC
(43)
Hcv Dna Vaccine Ino-8000
Hepatitis C Virus Infection
National Cancer Institute (NCI)
P1
CC
(43)
Hepatitis B Virus Vaccine
Bladder Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
il-22bp mrna vaccine
mRNA Vaccine
Xingchen Peng
P1
CC
(43)
il-22bp mrna vaccine
Refractory Malignant Neoplasm
Xingchen Peng
P1
CC
(43)
Inalimarev
Pancreatic Acinar Cell Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Inalimarev
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Kras-Epha-2-Car-Dc
EphA2 Overexpression
Chinese PLA General Hospital
P1
CC
(43)
Showing 451 to 475 of 748 assets
Previous
Page 19 of 30
Next